Saxony aims to be new Euro bio hub
five-year investment programme in a bid to nurture the development
of 'biosaxony,' centring on the establishment of regional
biotechnology hot spots in Leipzig and Dresden.
The German state of Saxony has implemented a $230 million, five-year investment program in a bid to nurture the development of 'biosaxony,' centring on the establishment of regional biotechnology hot spots in Leipzig and Dresden.
Bio City Leipzig, which has just opened, will concentrate on research in the field of tissue engineering and biomedicine and, at the same time, act as an incubator for start-up companies. The investment costs of approximately €50 million have been borne by the state of Saxony and the city of Leipzig.
Three quarters of the 215, 280 square feet of laboratory and production space in this one part of biosaxony will be rented out to start-ups and established biotech companies, and the remainder will be used by the University of Leipzig.
Companies that have migrated to the bio-incubator include DNA engineering company Gene Bridges and genomics company Cenix BioScience.
